Cephalon to pay $425M for improper marketing
Federal authorities have announced a $425 million civil settlement with a pharmaceutical company charged with off-label drug marketing.
Cephalon Concludes All Outstanding Federal and State Government Investigations into the Company’s Sales and Promotional Practices
Company Finalizes Previously Announced Agreement with U.S. Attorney’s Office for Eastern District of Pennsylvania and U.S. Department of Justice
Settles State Cases with Connecticut and Massachusetts
FRAZER, Pa., Sept. 29 /PRNewswire-FirstCall/ –…
ImClone Systems Issues Statement
NEW YORK, Sept. 29, 2008–(BUSINESS WIRE)–ImClone Systems Incorporated (NASDAQ: IMCL) announced today that the large Pharma company that had made an offer to acquire ImClone at $70 per share, subject to due diligence, but not financing, has…
FDA Grants Lilly’s Alimta (Pemetrexed for Injection) Third U.S. Approval
First-Line Chemotherapy Regimen Showed Clinically Relevant Survival Differences in Specific Histology Types of Advanced Non-Small Cell Lung Cancer
INDIANAPOLIS, Sept. 29 /PRNewswire-FirstCall/ — Eli Lilly and Company (NYSE:LLY) announced today it…
ImClone Systems Issues Statement
NEW YORK–(BUSINESS WIRE)–ImClone Systems Incorporated (NASDAQ: IMCL) announced today that the large Pharma company that had made an offer to acquire ImClone at $70 per share, subject to due diligence, but not financing, has informed ImClone that…
Chinese aphrodisiac may outperform Viagra
Tablets of Pfizer’s erectile dysfunction drug Viagra. Italian researchers are testing a promising alternative to Viagra that they’re calling 3,7-bis- -icaritin — or more simply put, “horny goat weed.” In lab …
FDA Continues to Review Prasugrel New Drug Application
TOKYO and INDIANAPOLIS, Sept. 26 /PRNewswire-FirstCall/ — Daiichi Sankyo Company, Limited, and Eli Lilly and Company (NYSE:LLY) confirmed today that the U.S. Food and Drug Administration (FDA) did not complete its review for the prasugrel new drug…
FDA Issues Several Letters for ADHD Drugs
ROCKVILLE, Md., Sept. 26, 2008–The FDA posted on its website Friday letters to several drug companies about their ADHD drugs. The letters and promotional materials are…
WuXi PharmaTech (NYSE:WX) Maintains Original Strategy to Provide Toxicology Services in China
SHANGHAI, China, Sept. 29 /Xinhua-PRNewswire/ — WuXi PharmaTech (NYSE:WX) , a leading pharmaceutical, biotechnology and medical device research and development outsourcing company with operations in China and the United States, announced…
Cardinal Health Plans to Spin Off Clinical and Medical Products Businesses, Creating Global Leader in Medical Technology
David L. Schlotterbeck to be named chairman and CEO of new company
George S. Barrett to be named Cardinal Health chairman and CEO, succeeding R. Kerry Clark who will retire following spin-off
DUBLIN, Ohio, Sept. 29 /PRNewswire-FirstCall/ — Cardinal…